Clinical Trial Update: Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

View source ↗

Summary

A clinical trial evaluating the effects of anti-PD1 adjuvant checkpoint blockade immunotherapy on atypical/dysplastic nevi in melanoma patients is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 inhibitor (anti-PD1 checkpoint blockade) (PD-1 inhibitor)

Snippet

Sponsor: John Kirkwood | Conditions: Melanoma | Status: RECRUITING